Long COVID Symptom Management Through Self-Care and Nonprescription Treatment Options: A Narrative Review
International Journal of Environmental Research and Public Health · 2025
DOI: 10.3390/ijerph22091362 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Environmental Research and Public Health, 2025. Verfasst von Preeti Kachroo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Global Category Medical Affairs, Haleon Plc., 1260 Nyon, Switzerland. Hauptthemen laut MEDLINE: COVID-19, Self Care. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Haleon.
Abstract (Originalsprache)
Many patients experience unique or persistent symptoms several months following the onset of infection with severe acute respiratory syndrome coronavirus 2, the causative agent of COVID-19. While this condition is commonly referred to as long COVID, no universally accepted definition exists; therefore, many patients go underrecognized and underreported. Long COVID can involve almost any major organ system and is characterized by widely heterogeneous persistent or recurrent symptoms including fatigue, headache, cough, dyspnea, chest pain, cognitive dysfunction, anxiety, and depression. In line with the wide array of symptoms, numerous potential underlying pathophysiologic pathways, including viral persistence, prolonged inflammation, autoimmune reactions, endothelial dysfunction, and dysbiosis of the microbiome of the gut, may contribute to the symptomology of long COVID. Therapy is directed at symptomatic control; however, no pharmacologic treatments are specifically approved for the management of symptoms associated with long COVID. Several common symptoms of long COVID may be managed with nonprescription treatments (pharmacologic and nonpharmacologic). The goal of this review is to provide clinicians with a better understanding of long COVID and review the latest recommendations for managing common mild-to-moderate symptoms with nonprescription treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Category Medical Affairs, Haleon Plc., 1260 Nyon, Switzerland.
- Department of Pediatric, Faculty of Medicine, Laval University, Quebec, QC G1V 0A6, Canada.
- School of Public Health, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
- Pinnacle Health Clinic, North Parramatta, NSW 2151, Australia.
- Global Category Medical Affairs, Haleon Plc., London KT13 0NY, UK.
ORCID-Profile: Preeti Kachroo, Guy Boivin, Will Shannon
Förderung
- Haleon
Zitieren
APA
Kachroo, P., Boivin, G., Cowling, B. J., Shannon, W., Mallefet, P., Kalita, P., & Georgescu, A. M. (2025). Long COVID Symptom Management Through Self-Care and Nonprescription Treatment Options: A Narrative Review. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph22091362
Vancouver
Kachroo P, Boivin G, Cowling BJ, Shannon W, Mallefet P, Kalita P, et al. Long COVID Symptom Management Through Self-Care and Nonprescription Treatment Options: A Narrative Review. International Journal of Environmental Research and Public Health. 2025. doi:10.3390/ijerph22091362
BibTeX
@article{Kachroo2025,
author = {Kachroo, Preeti and Boivin, Guy and Cowling, Benjamin J and Shannon, Will and Mallefet, Pascal and Kalita, Pranab and Georgescu, Alexandru M},
title = {Long COVID Symptom Management Through Self-Care and Nonprescription Treatment Options: A Narrative Review},
journal = {International Journal of Environmental Research and Public Health},
year = {2025},
doi = {10.3390/ijerph22091362}
}
EUVIMED